Eric Hedrick
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
- Co-authors
- Axel Grothey (7 shared papers)Daniel J. Sargent (4 shared papers)Mary M. Sugrue (4 shared papers)Mark Kozloff (2 shared papers)David M. Purdie (1 shared paper)Wei Dong (1 shared paper)Ramesh K. Ramanathan (4 shared papers)Barrett H. Childs (3 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Blood (12 papers)Hematological Oncology (3 papers)Haematologica (1 paper)Materials (1 paper)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Eric Hedrick
41 papers receiving 4.0k citations
Eric Hedrick's Hit Papers
Peers
Comparison fields: 5 of 94
- Genetics 1.3k
- Pathology and Forensic Medicine 1.7k
- Oncology 1.9k
- Hepatology 281
- Hematology 395
Countries citing papers authored by Eric Hedrick
This map shows the geographic impact of Eric Hedrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Hedrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Hedrick more than expected).
Fields of papers citing papers by Eric Hedrick
This network shows the impact of papers produced by Eric Hedrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Hedrick. The network helps show where Eric Hedrick may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Hedrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies Hit paper breakdown → | 2012 | 856 |
| 2 | Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE) Hit paper breakdown → | 2008 | 520 |
| 3 | Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study Hit paper breakdown → | 2018 | 462 |
| 4 | 2008 | 456 | |
| 5 | 2001 | 312 | |
| 6 | 1999 | 230 | |
| 7 | 2008 | 145 | |
| 8 | 2002 | 140 | |
| 9 | 2003 | 109 | |
| 10 | 2006 | 107 | |
| 11 | 2000 | 99 | |
| 12 | 2015 | 96 | |
| 13 | 2006 | 77 | |
| 14 | 2001 | 52 | |
| 15 | 2012 | 51 | |
| 16 | 2022 | 47 | |
| 17 | 2011 | 45 | |
| 18 | 2011 | 34 | |
| 19 | 2007 | 31 | |
| 20 | 2012 | 29 |
About Eric Hedrick
Eric Hedrick is a scholar working on Genetics, Oncology, Pathology and Forensic Medicine, Molecular Biology and Hematology, having authored 41 papers that have together received 4.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (17 papers), Colorectal Cancer Treatments and Studies (12 papers), Chronic Myeloid Leukemia Treatments (6 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Treatment and Pharmacology (5 papers), Viral-associated cancers and disorders (5 papers) and Gastric Cancer Management and Outcomes (4 papers). The work is most often cited by research in Genetics (1.3k citations), Pathology and Forensic Medicine (1.7k citations), Oncology (1.9k citations), Hepatology (281 citations) and Hematology (395 citations). Eric Hedrick has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Axel Grothey, Daniel J. Sargent, Mary M. Sugrue, Mark Kozloff, David M. Purdie, Wei Dong, Ramesh K. Ramanathan, Barrett H. Childs, John D. Hainsworth and Jeff P. Sharman. Their work appears in journals such as Journal of Clinical Oncology, Blood, Hematological Oncology, Haematologica and Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.